fashion -WSS

fashion

author：Wikipedia 2025-10-02 00:52:15 - browse：19999

The ability of cancer cells to move and spread depends on actin-rich core structures such as the podosomes (yellow) shown here in melanoma cells. Cell nuclei (blue), actin (red), and an actin regulator (green) are also shown. — Metastatic melanoma cells Julio C. Valencia,/NCI Center for Cancer Research

Nearly four decades after its first conception, the first TIL therapy, an immunotherapy that harvests cancer-fighting immune cells from the patient’s own body, received accelerated approval from the Food and Drug Administration for advanced melanoma. The therapy, called Amtagvi or lifileucel from Iovance, is the first cell therapy approved for a solid tumor.

“It’s so exciting and gratifying,” said Allison Betof Warner, a cell therapy researcher and physician at Stanford University who has worked on Amtagvi. “This is a game-changing moment for our field. We’ve seen huge success of cellular therapy for hematologic malignancies, and we’ve yet to capitalize on that for solid tumors. This is hopefully the first of many to come.”

In a Phase 2 clinical trial, titled C-144-01, 153 patients who had already been on a median of three prior lines of therapy received lifileucel, and 31% of them responded to therapy. “These are in very late line patients. They’ve exhausted every standard care option,” Betof Warner said. “The most promising part of this therapy for me is that 42% of patients who responded were still responding for 18 months or longer. It’s truly incredible.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： My superpower is killing ticks

WSS

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Dexcom's push to bring CGM to type 2 diabetes patients

Security flaws in third

White House drug shortage group privately met with industry

Drug cartel violence flares in western Mexico after vigilante leader's killing

hotspot

fashion

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Dramatically reducing cancer deaths requires the PASTEUR Act

Activists slam private health insurers over coverage restrictions

For BCIs, commercial hurdles may be bigger than scientific ones

Bright Health sells Medicare Advantage business to Molina

Undocumented workers face uncertainty as immigration law takes effect in Florida

Medical records are filled with copy

What Henrietta Lacks settlement says about racism in medicine

Peter Hotez and the public health issue of online harassment

Humana, CVS hope to turn members into patients at clinics

focus

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

Biden calls for immediate release of Niger's president amid apparent coup

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Hubble vs. James Webb telescope images: See the difference

ER docs worry over extreme heat as a 'mass casualty event'

Dramatically reducing cancer deaths requires the PASTEUR Act

knowledge

entertainment

leisure time

focus